Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy
- 1 August 2007
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 120 (2) , e291-e296
Abstract
OBJECTIVE. Berardinelli-Seip syndrome is a rare congenital lipoatrophy with a severe prognosis and no efficient therapy. Children present with low leptin levels and severe metabolic complications (insulin resistance, elevated triglyceride levels, and hepatic steatosis). The objective of this study was to test safety and efficacy of recombinant-methionyl-human leptin replacement in children with Berardinelli-Seip syndrome before development of severe metabolic disease METHODS. As part of an open trial, recombinant-methionyl-human leptin was given daily for 4 months to children who did not have diabetes and had Berardinelli-Seip congenital lipoatrophy and metabolic complications at a dosage that was meant to achieve physiologic levels. Six boys and 1 girl (age: 2.4–13.6 years), with a mean fasting insulin level of >15 mIU/L and hypertriglyceridemia, were included. RESULTS. At the end of the recombinant-methionyl-human leptin treatment, a 63% reduction of fasting triglycerides level was achieved. A simultaneous 30% increase in insulin sensitivity was seen, and liver volume was reduced by 20.3%. More remarkable, values of insulin sensitivity and triglyceride level were in the reference range in 4 patients. CONCLUSIONS. Leptin replacement is able to reverse metabolic complications in the majority of children with Berardinelli-Seip congenital lipoatrophy and with insulin resistance or dyslipidemia before the development of overt diabetes.Keywords
This publication has 17 references indexed in Scilit:
- Long-Term Leptin-Replacement Therapy for Lipoatrophic DiabetesNew England Journal of Medicine, 2004
- Leptin in Morbidly Obese Patients: No Role for Treatment of Morbid Obesity but Important in the Postoperative Immune ResponseObesity Surgery, 2004
- Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophyJournal of Clinical Investigation, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Detection of Insulin Resistance by Simple Quantitative Insulin Sensitivity Check Index QUICKI for Epidemiological Assessment and PreventionThe Journal of Clinical Endocrinology & Metabolism, 2002
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansThe Journal of Clinical Endocrinology & Metabolism, 2000
- Recombinant Leptin for Weight Loss in Obese and Lean AdultsJAMA, 1999
- Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin DeficiencyNew England Journal of Medicine, 1999
- Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjectsNature Medicine, 1995
- Generalized LipodystrophyArchives of Disease in Childhood, 1963